Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Typesort ascending Project # RFA # PI/Project Leader Institution Title Status
1999 R33 PAR-98-067 DOVICHI, NORMAN J UNIVERSITY OF ALBERTA SINGLE CELL PROTEOME PROJECT--CANCER PROGNOSIS Complete
2001 R33 PAR-99-102 SMITH, RICHARD D BATTELLE PACIFIC NORTHWEST LABORATORIES HIGH THROUGHPUT FTICR FOR MOLECULAR ANALYSIS OF CANCER Complete
2020 R33 RFA-CA-19-020 FAN, RONG YALE UNIVERSITY High-throughput single-cell co-sequencing of small and large RNAs to identify molecular circuitry in cancer Complete
2000 R33 PAR-98-067 SINGER, ROBERT H YESHIVA UNIVERSITY FISH AND CHIPS--SINGLE CELL EXPRESSION OF CANCER GENES Complete
2002 R33 PAR-99-102 ALBERTSON, DONNA G UNIVERSITY OF CALIFORNIA SAN FRANCISCO AMPLICON PROFILING BY ARRAY CGH Complete
2023 R33 RFA-CA-22-004 BRUDNO, YEVGENY NORTH CAROLINA STATE UNIVERSITY RALEIGH MASTER Scaffolds for Rapid, Single-Step Manufacture and Prototyping of CAR-T cells Active
2022 R33 CA21-004 MERAJVER, SOFIA DIANA UNIVERSITY OF MICHIGAN AT ANN ARBOR Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence Active
1999 R33 PAR-98-067 LIZARDI, PAUL M. YALE UNIVERSITY MESSENGER RNA PROFILING BY SINGLE MOLECULE COUNTING Complete
2001 R33 PAR-99-102 DAVIS, RONALD WAYNE STANFORD UNIVERSITY TARGET IDENTIFICATION VIA HAPLO INSUFFICIENCY PROFILING Complete
2021 R33 RFA-CA-20-018 JI, HANLEE P STANFORD UNIVERSITY Multimodal iterative sequencing of cancer genomes and single tumor cells Active
2016 R33 RFA-CA-15-005 AKSAN, ALPTEKIN UNIVERSITY OF MINNESOTA VALIDATION OF A ROOM-TEMPERATURE STORAGE TECHNIQUE FOR PLASMA/SERUM BIOSPECIMENS Complete
2000 R33 PAR-98-067 TOLIAS, PETER P PUBLIC HEALTH RESEARCH INSTITUTE FUNCTIONAL CLONING OF DNA AND RNA BINDING PROTEINS Complete
2002 R33 PAR-99-102 ALLBRITTON, NANCY L UNIVERSITY OF CALIFORNIA IRVINE PROFILING RAS ACTIVATED SIGNAL TRANSDUCTION PATHWAYS Complete
2023 R33 RFA-CA-22-002 KLEIN, ALLON MOSHE HARVARD MEDICAL SCHOOL Micro-capsules for versatile multiplexed cytometry Active
2022 R33 CA21-004 ADEY, ANDREW OREGON HEALTH & SCIENCE UNIVERSITY Accessible high-throughput single-cell genome sequencing Active
1999 R33 PAR-98-067 CHALMERS, JEFFREY JOHN OHIO STATE UNIVERSITY RAPID RARE CANCER CELL ISOLATION FOR MOLECULAR DIAGNOSIS Complete
2001 R33 PAR-99-102 DABORA, SANDRA L BRIGHAM AND WOMEN'S HOSPITAL MUTANT ANALYSIS OF TSC1 & TSC2 IN TSC RELATED DISORDERS Complete
2021 R33 RFA-CA-20-018 GARTNER, ZEV JORDAN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO Universal Sample Multiplexing for Single Cell Analysis Active
2016 R33 RFA-CA-15-005 JOHANN, DONALD UNIV OF ARKANSAS FOR MED SCIS DEVELOPMENT AND VALIDATION OF A MICRODISSECTION METHOD TO ADVANCE PRECISION MEDICINE IN THE CLINICAL SETTING Complete
2020 R33 RFA-CA-19-022 HASHAM, MUNEER GULAMHUSEIN JACKSON LABORATORY Impact of Genetic Diversity on Human Xenograft Tumor Growth Complete
2000 R33 PAR-98-067 AEBERSOLD, RUEDI H. UNIVERSITY OF WASHINGTON ISOTOPE CODED AFFINITY TAGS FOR QUANTITATIVE PROTEOMICS Complete
2002 R33 PAR-99-102 ZHOU, PENGBO WEILL MEDICAL COLLEGE OF CORNELL UNIV PROTEIN KNOCKOUT TECHNOLOGY/MOLECULAR ANALYSIS OF CANCER Complete
2022 R33 RFA-CA-21-004 LEE, ABRAHAM P UNIVERSITY OF CALIFORNIA-IRVINE Microfluidic Precision Engineered Artificial Antigen Presenting Cells for Cancer Immunotherapy Active
2018 R33 RFA-CA-17-011 BROWN, BRIAN D ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI Pro-Codes: A novel vector and cell barcoding technology Complete
2022 R33 CA21-004 KARGINOV, ANDREI V UNIVERSITY OF ILLINOIS AT CHICAGO Optogenetic Control of Tumor Initiation and Tumor Progression in vivo Active
1999 R33 PAR-98-067 MCCLELLAND, MICHAEL SIDNEY KIMMEL CANCER CENTER REDUCED COMPLEXITY CDNA PROBES Complete
2001 R33 PAR-99-102 WEIER, HEINZ-ULRICH G UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB SPECTRAL IMAGING FOR PHENOTYPE ANALYSIS OF CANCER CELLS Complete
2004 R33 PAR-01-104 O'LEARY, TIMOTHY J. AMERICAN REGISTRY OF PATHOLOGY, INC. RECOVERY OF PROTEIN FROM FORMALIN-FIXED TISSUES Complete
2021 R33 RFA-CA-20-020 HAUN, JERED BRACKSTON UNIVERSITY OF CALIFORNIA-IRVINE Microfluidic tumor tissue processing platform for single cell diagnostics Active
2016 R33 RFA-CA-15-005 SOKER, SHAY WAKE FOREST UNIVERSITY HEALTH SCIENCES BIOENGINEERED LUNG TUMOR ORGANOIDS FOR DEVELOPMENT OF PERSONALIZED MEDICINE Complete
2000 R33 PAR-99-100 JARVIK, JONATHAN W CARNEGIE-MELLON UNIVERSITY TECHNOLOGIES FOR COMPREHENSIVE FUNCTIONAL PROTEOMICS Complete
2002 R33 PAR-99-102 SPEICHER, DAVID W. WISTAR INSTITUTE NOVEL COMPREHENSIVE PROTEOME ANALYSES OF METASTASIS Complete
2018 R33 RFA-CA-17-011 CHENG, JI-XIN BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) Quantitative SRS Imaging of Cancer Metabolism at Single Cell Level Complete
1999 R33 PAR-98-067 RAMSEY, JOHN MICHAEL LOCKHEED MARTIN ENERGY RESEARCH CORP DEVICES FOR HIGH THROUGHPUT CELLULAR PROTEIN ANALYSIS Complete
2001 R33 PAR-99-102 BROCK, GRAHAM J UNIVERSITY OF GLASGOW IDENTIFICATION OF M5CPG ALTERATIONS IN BREAST CARCINOMAS Complete
2004 R33 PAR-01-104 MUDDIMAN, DAVID C. MAYO CLINIC OVARIAN CANCER SCREENING USING COMPREHENSIVE PROTEOMICS Complete
2017 R33 RFA-CA-16-002 LEVENSON, RICHARD M. UNIVERSITY OF CALIFORNIA AT DAVIS Cancer histology and QC via MUSE: Sample-sparing UV surface-excitation microscopy Complete
2021 R33 RFA-CA-20-018 SEELIG, GEORG UNIVERSITY OF WASHINGTON Joint receptor and protein expression immunophenotyping through split-pool barcoding Active
2003 R33 PAR-01-104 ARAP, WADIH UNIVERSITY OF TEXAS MD ANDERSON CAN CTR STEM CELL-BRAIN TUMOR INTERPLAY & IN VIVO PHAGE DISPLAY Complete
2000 R33 PAR-99-100 LAM, KIT S UNIVERSITY OF CALIFORNIA DAVIS LIGANDS FOR ALTERED PHOSPHOPROTEINS IN CANCER Complete
2018 R33 RFA-CA-17-011 CIMA, MICHAEL J MASSACHUSETTS INSTITUTE OF TECHNOLOGY Advanced development and validation of microdevices for high-throughput in situ drug sensitivity testing in tumors Complete
2022 R33 CA21-004 MOELLERING, RAYMOND E UNIVERSITY OF CHICAGO Single-Cell Protein Activity Profiling in Breast Cancer Cells and Tissues Active
1999 R33 PAR-98-067 YATES, JOHN ROBERT UNIVERSITY OF WASHINGTON DIRECT MS ANALYSIS OF COMPLEX PROTEIN MIXTURES Complete
2001 R33 PAR-99-102 GALE, JAMES M UNIVERSITY OF NEW MEXICO MOLECULAR STAGING OF HUMAN SQUAMOUS CELL SKIN CANCER Complete
2004 R33 PAR-01-106 VIDAL, MARC DANA-FARBER CANCER INSTITUTE INTEGRATED INTERACTOME MAPPING Complete
2007 R33 RFA-CA-07-001 MILOSAVLJEVIC, ALEKSANDAR BAYLOR COLLEGE OF MEDICINE MULTIPLEXED METHODS FOR THE STUDY OF CHROMOSOMAL ABERRATIONS IN CANCER Complete
2017 R33 RFA-CA-16-002 KELLEY, SHANA O UNIVERSITY OF TORONTO Development and validation of nanoparticle-mediated microfluidic profiling approach for rare cell analysis Complete
2021 R33 RFA-CA-20-018 GREENBERG, JOEL DUKE UNIVERSITY Multimodality X-ray transmission and diffraction scanner for molecular analysis of cancer specimens Active
2003 R33 PAR-01-104 TAYLOR, CLIVE R UNIVERSITY OF SOUTHERN CALIFORNIA RETRIEVAL OF DNA, RNA, AND PROTEIN FROM ARCHIVAL TISSUE Complete
2013 R33 RFA-CA-12-003 JI, HANLEE P STANFORD UNIVERSITY OLIGONUCLEOTIDE-SELECTIVE SEQUENCING FOR INTEGRATED AND RAPID CANCER GENOME ANALY Complete

Pages